NeuroBo Pharmaceuticals | Securities Offering Presentation Deck | 30 slides · page 26 of 30
Includes footnotes regarding anti-dilution provisions and Dong-A license agreement terms.
Regulatory filing · valuation_table · analyze_data · balanced density
Slide locked Sign in to view
Slide schematic 3/3
source-note 1/1 table 1/1 title 1/1
Components 3
source-note valuation headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.